Page last updated: 2024-10-27

fluorouracil and Venous Insufficiency

fluorouracil has been researched along with Venous Insufficiency in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Venous Insufficiency: Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fronek, L1
Harrison, A1
Cooper, H1
Dorton, D1

Other Studies

1 other study available for fluorouracil and Venous Insufficiency

ArticleYear
Intralesional 5-fluorouracil utilizing abbreviated tourniquet device in patients with overlying stasis dermatitis or lymphedema.
    Dermatology online journal, 2021, Jul-15, Volume: 27, Issue:7

    Topics: Antimetabolites, Antineoplastic; Fluorouracil; Humans; Injections, Intralesional; Lymphedema; Skin N

2021